Itraconazole Pellets bulk supplier for pharma manufacturers

Itraconazole Pellets 100 mg or 200 mg Suppliers & Bulk Manufacturers

Available Forms: Pellets

Available Strengths: 100 mg or 200 mg

Reference Brands: Sporanox

Category: Active Pharmaceutical Ingredient

Itraconazole pellets inhibit fungal enolase enzyme, disrupting energy production and cell wall synthesis. They are effective against systemic fungi like aspergillosis and histoplasmosis. Benefits include excellent bioavailability, broad-spectrum antifungal activity, and improved treatment of invasive mycoses, supporting faster recovery and disease management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Itraconazole pellets API is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves validation, safety testing, and clinical validation. In the EU, CE marking certifies conformity under MDR regulations. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality itraconazole pellet APIs vital for treating systemic fungal infections worldwide, supporting effective disease management and patient outcomes.

Itraconazole Pellets — third party manufacturing & bulk supply

Itraconazole Pellets 100 mg or 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Itraconazole Pellets is supplied as Pellets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Itraconazole Pellets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Itraconazole Pellets →

Back to Listing

Frequently Asked Questions

Itraconazole Pellets is listed as Pellets in 100 mg or 200 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Itraconazole Pellets is referenced against Sporanox. Reference brands are shown for identification only and remain the property of their respective trademark owners.